17h
Verywell Mind on MSNLiving With Atopic DermatitisThe visible symptoms only scratch the surface of this chronic skin condition Living with a chronic condition like atopic ...
18h
Verywell Mind on MSNHow I Reframed the Way I Saw My Atopic DermatitisWhen my mind is struggling but I’m pretending I’m fine, my skin tells the truth My eczema doesn’t just show up on my skin—it ...
5d
Verywell Health on MSNHow to Test for Atopic DermatitisA patch test for atopic dermatitis helps identify triggers and confirms diagnosis. Learn about self-testing and specialists ...
Atopic Dermatitis AD and Contact Dermatitis CD are skin conditions that lead to skin inflammation however their causes and ...
Underlying social and economic barriers in the U.S. may play a significant role in the higher rates of atopic dermatitis.
Miyake and Masakatsu Yamashita has discovered that Bach2, a protein essential for regulating T cells function, plays a ...
4d
Verywell Health on MSNAsk an Expert: How Can You Tell Dry Skin From Atopic Dermatitis?Learn from a board-certified dermatologist how to differentiate dry skin from a condition like atopic dermatitis.
4d
News-Medical.Net on MSNBach2 protein identified as key regulator in atopic dermatitisAtopic dermatitis is an allergy affecting approximately 10% of the Japanese population, with symptoms closely related to ...
Reaction severity and skin prick testing results predicted persistent sesame allergy among children, according to a study published in Pediatric Allergy and Immunology. These risk factors can help ...
Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...
Atopic dermatitis highlights from AAD 2025 include phase 3 trial results on rocatinlimab and delgocitinib, findings on tapinarof 1% cream, and early dosing data on a new JAK1/TYK2 inhibitor.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results